English

MOLECULAR BIOSYSTEMS INC

EDGAR

Quarterly report (10-Q) · filed 2000-11-08

30 filing records in this dataset, filed from 1995-02-13 to 2000-11-08. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

338 thousand USD

2000-09-30 · USD

Exact inputs and evidence

Revenue: 338000 USD Source

Operating margin

-175.44%

2000-09-30 · %

Exact inputs and evidence

Operating Income: -593000 USD Source
Revenue: 338000 USD Source

Operating cash flow

-5.51 million USD

2000-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -3872000 USD Source
Operating Cash Flow: 1637000 USD Source

Free cash flow

-5.51 million USD

2000-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -3872000 USD Source
Operating Cash Flow: 1637000 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 2.93 million USD 2000-09-30 Source
Exact value

2930000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

8.48 million USD

1999-10-01 – 2000-09-30

Exact inputs and evidence

Revenue: 2493000 USD · 1999-10-01 – 1999-12-31 Source
Revenue: 8525000 USD · 1999-04-01 – 2000-03-31 Source
Revenue: 6010000 USD · 1999-04-01 – 1999-12-31 Source
Revenue: 3133000 USD · 2000-04-01 – 2000-06-30 Source
Revenue: 338000 USD · 2000-07-01 – 2000-09-30 Source

Net income

-6.02 million USD

1999-10-01 – 2000-09-30

Exact inputs and evidence

Net income: -1290000 USD · 1999-10-01 – 1999-12-31 Source
Net income: -7568000 USD · 1999-04-01 – 2000-03-31 Source
Net income: -3622000 USD · 1999-04-01 – 1999-12-31 Source
Net income: -282000 USD · 2000-04-01 – 2000-06-30 Source
Net income: -502000 USD · 2000-07-01 – 2000-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2000-11-08.

Financial data available through: 2000-03-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2000-03-31
Operating income: 8 of 11 periods available· newest 2000-03-31
Net income: 8 of 11 periods available· newest 2000-03-31
Operating cash flow: 8 of 11 periods available· newest 2000-03-31
Capital expenditure: 8 of 11 periods available· newest 2000-03-31
Total assets: 8 of 11 periods available· newest 2000-03-31
liabilities: No compatible figures in this window
Current assets: 7 of 11 periods available· newest 2000-03-31
Current liabilities: 7 of 11 periods available· newest 2000-03-31
Cash and cash equivalents: 8 of 11 periods available· newest 2000-03-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-11%

Prior period

USD 9.58 million

1998-04-01 – 1999-03-31
Current period

USD 8.53 million

1999-04-01 – 2000-03-31

Exact inputs and evidence

8525000 − 9581000 = -1056000 USD

9581000 USD · 1998-04-01 – 1999-03-31
Inspect prior input Prior source
8525000 USD · 1999-04-01 – 2000-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MOLECULAR BIOSYSTEMS INC · 2000-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Year-over-year change in Revenue: -1056000 USD Concept: fundies:Revenue Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 8525000 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1603 Input fundies:Revenue: 9581000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1603
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 13.67 million

Prior period

−USD 21.24 million

1998-04-01 – 1999-03-31
Current period

−USD 7.57 million

1999-04-01 – 2000-03-31

Exact inputs and evidence

-7568000 − -21240000 = 13672000 USD

-21240000 USD · 1998-04-01 – 1999-03-31
Inspect prior input Prior source
-7568000 USD · 1999-04-01 – 2000-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MOLECULAR BIOSYSTEMS INC · 2000-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Year-over-year change in Net income: 13672000 USD Concept: fundies:NetIncome Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -7568000 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1740 Input fundies:NetIncome: -21240000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1740
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 23 million

Prior period

−USD 26.53 million

1998-04-01 – 1999-03-31
Current period

−USD 3.53 million

1999-04-01 – 2000-03-31

Exact inputs and evidence

-3525000 − -26528000 = 23003000 USD

-26528000 USD · 1998-04-01 – 1999-03-31
Inspect prior input Prior source
-3525000 USD · 1999-04-01 – 2000-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MOLECULAR BIOSYSTEMS INC · 2000-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Year-over-year change in Operating cash flow: 23003000 USD Concept: fundies:OperatingCashFlow Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -3525000 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1755 Input fundies:OperatingCashFlow: -26528000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1755
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-98.4%

Prior period

USD 791,000

1998-04-01 – 1999-03-31
Current period

USD 13,000

1999-04-01 – 2000-03-31

Exact inputs and evidence

13000 − 791000 = -778000 USD

791000 USD · 1998-04-01 – 1999-03-31
Inspect prior input Prior source
13000 USD · 1999-04-01 – 2000-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MOLECULAR BIOSYSTEMS INC · 2000-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Year-over-year change in Capital expenditure: -778000 USD Concept: fundies:CapitalExpenditure Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 13000 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1758 Input fundies:CapitalExpenditure: 791000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1758
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2000 1999-04-01 – 2000-03-31

Revenue USD 8.53 million 100% of revenue
Operating costs Derived USD 15.97 million 187% of revenue
Operating income −USD 7.45 million −87% of revenue
Tax, interest and other Derived USD 120,000 1.4% of revenue
Net income −USD 7.57 million −89% of revenue

Cash

Operating cash flow −USD 3.53 million −41% of revenue
Capital expenditure USD 13,000 0.2% of revenue
Free cash flow Derived −USD 3.54 million −42% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1993 Operating loss: operating costs were 529% of revenue.
1994 Operating loss: operating costs were 332% of revenue.
1995 Operating loss: operating costs were 175% of revenue.
1996 Operating loss: operating costs were 782% of revenue.
1997 Operating loss: operating costs were 443% of revenue.
1998 Operating loss: operating costs were 461% of revenue.
1999 Operating loss: operating costs were 389% of revenue.
2000 Operating loss: operating costs were 187% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1993 1992-04-01 – 1993-03-31	3689000	19503000 Derived	-15814000	-1746000 Derived	-14068000	-17370000 Derived	Source 1992-04-01 – 1993-03-31: 3689000 USD Inspect Revenue Open source 1992-04-01 – 1993-03-31: -15814000 USD Inspect Operating Income Open source 1992-04-01 – 1993-03-31: -14068000 USD Inspect Net Income Open source 1992-04-01 – 1993-03-31: -15589000 USD Inspect Operating Cash Flow Open source 1992-04-01 – 1993-03-31: 1781000 USD Inspect Capital Expenditure Open source
1994 1993-04-01 – 1994-03-31	8784000	29159000 Derived	-20375000	-1575000 Derived	-18800000	-22872000 Derived	Source 1993-04-01 – 1994-03-31: 8784000 USD Inspect Revenue Open source 1993-04-01 – 1994-03-31: -20375000 USD Inspect Operating Income Open source 1993-04-01 – 1994-03-31: -18800000 USD Inspect Net Income Open source 1993-04-01 – 1994-03-31: -14664000 USD Inspect Operating Cash Flow Open source 1993-04-01 – 1994-03-31: 8208000 USD Inspect Capital Expenditure Open source
1995 1994-04-01 – 1995-03-31	16941000	29618000 Derived	-12677000	-495000 Derived	-12182000	-14034000 Derived	Source 1994-04-01 – 1995-03-31: 16941000 USD Inspect Revenue Open source 1994-04-01 – 1995-03-31: -12677000 USD Inspect Operating Income Open source 1994-04-01 – 1995-03-31: -12182000 USD Inspect Net Income Open source 1994-04-01 – 1995-03-31: -11506000 USD Inspect Operating Cash Flow Open source 1994-04-01 – 1995-03-31: 2528000 USD Inspect Capital Expenditure Open source
1996 1995-04-01 – 1996-03-31	3084000	24113000 Derived	-21029000	-316000 Derived	-20713000	-14466000 Derived	Source 1995-04-01 – 1996-03-31: 3084000 USD Inspect Revenue Open source 1995-04-01 – 1996-03-31: -21029000 USD Inspect Operating Income Open source 1995-04-01 – 1996-03-31: -20713000 USD Inspect Net Income Open source 1995-04-01 – 1996-03-31: -12069000 USD Inspect Operating Cash Flow Open source 1995-04-01 – 1996-03-31: 2397000 USD Inspect Capital Expenditure Open source
1997 1996-04-01 – 1997-03-31	5126000	22702000 Derived	-17576000	-4292000 Derived	-13284000	-14201000 Derived	Source 1996-04-01 – 1997-03-31: 5126000 USD Inspect Revenue Open source 1996-04-01 – 1997-03-31: -17576000 USD Inspect Operating Income Open source 1996-04-01 – 1997-03-31: -13284000 USD Inspect Net Income Open source 1996-04-01 – 1997-03-31: -13475000 USD Inspect Operating Cash Flow Open source 1996-04-01 – 1997-03-31: 726000 USD Inspect Capital Expenditure Open source
1998 1997-04-01 – 1998-03-31	6246000	28781000 Derived	-22535000	-1275000 Derived	-21260000	-18846000 Derived	Source 1997-04-01 – 1998-03-31: 6246000 USD Inspect Revenue Open source 1997-04-01 – 1998-03-31: -22535000 USD Inspect Operating Income Open source 1997-04-01 – 1998-03-31: -21260000 USD Inspect Net Income Open source 1997-04-01 – 1998-03-31: -17459000 USD Inspect Operating Cash Flow Open source 1997-04-01 – 1998-03-31: 1387000 USD Inspect Capital Expenditure Open source
1999 1998-04-01 – 1999-03-31	9581000	37234000 Derived	-27653000	-6413000 Derived	-21240000	-27319000 Derived	Source 1998-04-01 – 1999-03-31: 9581000 USD Inspect Revenue Open source 1998-04-01 – 1999-03-31: -27653000 USD Inspect Operating Income Open source 1998-04-01 – 1999-03-31: -21240000 USD Inspect Net Income Open source 1998-04-01 – 1999-03-31: -26528000 USD Inspect Operating Cash Flow Open source 1998-04-01 – 1999-03-31: 791000 USD Inspect Capital Expenditure Open source
2000 1999-04-01 – 2000-03-31	8525000	15973000 Derived	-7448000	120000 Derived	-7568000	-3538000 Derived	Source 1999-04-01 – 2000-03-31: 8525000 USD Inspect Revenue Open source 1999-04-01 – 2000-03-31: -7448000 USD Inspect Operating Income Open source 1999-04-01 – 2000-03-31: -7568000 USD Inspect Net Income Open source 1999-04-01 – 2000-03-31: -3525000 USD Inspect Operating Cash Flow Open source 1999-04-01 – 2000-03-31: 13000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 8.5M 2000

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-03-31	Revenue	3689000	Revenue: 3689000 Open source
19941994-03-31	Revenue	8784000	Revenue: 8784000 Open source
19951995-03-31	Revenue	16941000	Revenue: 16941000 Open source
19961996-03-31	Revenue	3084000	Revenue: 3084000 Open source
19971997-03-31	Revenue	5126000	Revenue: 5126000 Open source
19981998-03-31	Revenue	6246000	Revenue: 6246000 Open source
19991999-03-31	Revenue	9581000	Revenue: 9581000 Open source
20002000-03-31	Revenue	8525000	Revenue: 8525000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-11% 2000

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19931993-03-31	Year over year	No prior comparable period	Revenue: 3689000 Open source
19941994-03-31	Year over year	138.1%	Revenue: 8784000 Open source Revenue: 3689000 Open source
19951995-03-31	Year over year	92.9%	Revenue: 16941000 Open source Revenue: 8784000 Open source
19961996-03-31	Year over year	-81.8%	Revenue: 3084000 Open source Revenue: 16941000 Open source
19971997-03-31	Year over year	66.2%	Revenue: 5126000 Open source Revenue: 3084000 Open source
19981998-03-31	Year over year	21.8%	Revenue: 6246000 Open source Revenue: 5126000 Open source
19991999-03-31	Year over year	53.4%	Revenue: 9581000 Open source Revenue: 6246000 Open source
20002000-03-31	Year over year	-11%	Revenue: 8525000 Open source Revenue: 9581000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -87.4% 2000

Net margin -88.8% 2000

Free cash flow margin -41.5% 2000

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19931993-03-31	Operating margin	-428.7%	Operating Income: -15814000 Open source Revenue: 3689000 Open source
19941994-03-31	Operating margin	-232%	Operating Income: -20375000 Open source Revenue: 8784000 Open source
19951995-03-31	Operating margin	-74.8%	Operating Income: -12677000 Open source Revenue: 16941000 Open source
19961996-03-31	Operating margin	-681.9%	Operating Income: -21029000 Open source Revenue: 3084000 Open source
19971997-03-31	Operating margin	-342.9%	Operating Income: -17576000 Open source Revenue: 5126000 Open source
19981998-03-31	Operating margin	-360.8%	Operating Income: -22535000 Open source Revenue: 6246000 Open source
19991999-03-31	Operating margin	-288.6%	Operating Income: -27653000 Open source Revenue: 9581000 Open source
20002000-03-31	Operating margin	-87.4%	Operating Income: -7448000 Open source Revenue: 8525000 Open source
19931993-03-31	Net margin	-381.3%	Net Income: -14068000 Open source Revenue: 3689000 Open source
19941994-03-31	Net margin	-214%	Net Income: -18800000 Open source Revenue: 8784000 Open source
19951995-03-31	Net margin	-71.9%	Net Income: -12182000 Open source Revenue: 16941000 Open source
19961996-03-31	Net margin	-671.6%	Net Income: -20713000 Open source Revenue: 3084000 Open source
19971997-03-31	Net margin	-259.1%	Net Income: -13284000 Open source Revenue: 5126000 Open source
19981998-03-31	Net margin	-340.4%	Net Income: -21260000 Open source Revenue: 6246000 Open source
19991999-03-31	Net margin	-221.7%	Net Income: -21240000 Open source Revenue: 9581000 Open source
20002000-03-31	Net margin	-88.8%	Net Income: -7568000 Open source Revenue: 8525000 Open source
19931993-03-31	Free cash flow margin	-470.9%	Revenue: 3689000 Open source Operating Cash Flow: -15589000 Open source Capital Expenditure: 1781000 Open source
19941994-03-31	Free cash flow margin	-260.4%	Revenue: 8784000 Open source Operating Cash Flow: -14664000 Open source Capital Expenditure: 8208000 Open source
19951995-03-31	Free cash flow margin	-82.8%	Revenue: 16941000 Open source Operating Cash Flow: -11506000 Open source Capital Expenditure: 2528000 Open source
19961996-03-31	Free cash flow margin	-469.1%	Revenue: 3084000 Open source Operating Cash Flow: -12069000 Open source Capital Expenditure: 2397000 Open source
19971997-03-31	Free cash flow margin	-277%	Revenue: 5126000 Open source Operating Cash Flow: -13475000 Open source Capital Expenditure: 726000 Open source
19981998-03-31	Free cash flow margin	-301.7%	Revenue: 6246000 Open source Operating Cash Flow: -17459000 Open source Capital Expenditure: 1387000 Open source
19991999-03-31	Free cash flow margin	-285.1%	Revenue: 9581000 Open source Operating Cash Flow: -26528000 Open source Capital Expenditure: 791000 Open source
20002000-03-31	Free cash flow margin	-41.5%	Revenue: 8525000 Open source Operating Cash Flow: -3525000 Open source Capital Expenditure: 13000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -3.5M 2000

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-03-31	Operating cash flow	-15589000	Operating Cash Flow: -15589000 Open source
19941994-03-31	Operating cash flow	-14664000	Operating Cash Flow: -14664000 Open source
19951995-03-31	Operating cash flow	-11506000	Operating Cash Flow: -11506000 Open source
19961996-03-31	Operating cash flow	-12069000	Operating Cash Flow: -12069000 Open source
19971997-03-31	Operating cash flow	-13475000	Operating Cash Flow: -13475000 Open source
19981998-03-31	Operating cash flow	-17459000	Operating Cash Flow: -17459000 Open source
19991999-03-31	Operating cash flow	-26528000	Operating Cash Flow: -26528000 Open source
20002000-03-31	Operating cash flow	-3525000	Operating Cash Flow: -3525000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -3.5M 2000

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-03-31	Free cash flow	-17370000	Operating Cash Flow: -15589000 Open source Capital Expenditure: 1781000 Open source
19941994-03-31	Free cash flow	-22872000	Operating Cash Flow: -14664000 Open source Capital Expenditure: 8208000 Open source
19951995-03-31	Free cash flow	-14034000	Operating Cash Flow: -11506000 Open source Capital Expenditure: 2528000 Open source
19961996-03-31	Free cash flow	-14466000	Operating Cash Flow: -12069000 Open source Capital Expenditure: 2397000 Open source
19971997-03-31	Free cash flow	-14201000	Operating Cash Flow: -13475000 Open source Capital Expenditure: 726000 Open source
19981998-03-31	Free cash flow	-18846000	Operating Cash Flow: -17459000 Open source Capital Expenditure: 1387000 Open source
19991999-03-31	Free cash flow	-27319000	Operating Cash Flow: -26528000 Open source Capital Expenditure: 791000 Open source
20002000-03-31	Free cash flow	-3538000	Operating Cash Flow: -3525000 Open source Capital Expenditure: 13000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1993-03-31	Liabilities / assets	Not reported	Total Assets: 71758000 Open source
1994-03-31	Liabilities / assets	Not reported	Total Assets: 56051000 Open source
1995-03-31	Liabilities / assets	Not reported	Total Assets: 50639000 Open source
1996-03-31	Liabilities / assets	Not reported	Total Assets: 43829000 Open source
1997-03-31	Liabilities / assets	Not reported	Total Assets: 70159000 Open source
1998-03-31	Liabilities / assets	Not reported	Total Assets: 51318000 Open source
1999-03-31	Liabilities / assets	Not reported	Total Assets: 31849000 Open source
2000-03-31	Liabilities / assets	Not reported	Total Assets: 43829000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.37× 2000

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1993-03-31	Current assets / current liabilities	Not reported	No source recorded
19941994-03-31	Current assets / current liabilities	7.93×	Current Assets: 32175000 Open source Current Liabilities: 4058000 Open source
19951995-03-31	Current assets / current liabilities	4.6×	Current Assets: 26734000 Open source Current Liabilities: 5807000 Open source
19961996-03-31	Current assets / current liabilities	3.97×	Current Assets: 24858000 Open source Current Liabilities: 6257000 Open source
19971997-03-31	Current assets / current liabilities	4.01×	Current Assets: 36222000 Open source Current Liabilities: 9025000 Open source
19981998-03-31	Current assets / current liabilities	2.68×	Current Assets: 33638000 Open source Current Liabilities: 12572000 Open source
19991999-03-31	Current assets / current liabilities	1.99×	Current Assets: 21531000 Open source Current Liabilities: 10838000 Open source
20002000-03-31	Current assets / current liabilities	1.37×	Current Assets: 14270000 Open source Current Liabilities: 10446000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1993 1992-04-01 – 1993-03-31	−USD 14.07 million Exact value Exact value: -14068000 USD 1992-04-01 – 1993-03-31: -14068000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR BIOSYSTEMS INC · 1993-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Net Income: -14068000 USD Concept: fundies:NetIncome Period: 1992-04-01 to 1993-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ANetIncome&period=1993-03-31&surface=latest&period_type=duration&start=1992-04-01&unit=USD&dimensions= Input fundies:NetIncome: -14068000 USD (1992-04-01 to 1993-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-95-004935.txt#7258 The citation records this snapshot. The page link may show a newer release later.	−USD 15.59 million Exact value Exact value: -15589000 USD 1992-04-01 – 1993-03-31: -15589000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR BIOSYSTEMS INC · 1993-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Operating Cash Flow: -15589000 USD Concept: fundies:OperatingCashFlow Period: 1992-04-01 to 1993-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3AOperatingCashFlow&period=1993-03-31&surface=latest&period_type=duration&start=1992-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15589000 USD (1992-04-01 to 1993-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-95-004935.txt#7272 The citation records this snapshot. The page link may show a newer release later.	USD 1.78 million Exact value Exact value: 1781000 USD 1992-04-01 – 1993-03-31: 1781000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR BIOSYSTEMS INC · 1993-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Capital Expenditure: 1781000 USD Concept: fundies:CapitalExpenditure Period: 1992-04-01 to 1993-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ACapitalExpenditure&period=1993-03-31&surface=latest&period_type=duration&start=1992-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1781000 USD (1992-04-01 to 1993-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-95-004935.txt#7276 The citation records this snapshot. The page link may show a newer release later.	−USD 17.37 million Calculation and evidence -15589000 − 1781000 USD Exact free cash flow: -17370000 USD 1992-04-01 – 1993-03-31: -15589000 USD · Inspect Operating Cash Flow · Source 1992-04-01 – 1993-03-31: 1781000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR BIOSYSTEMS INC · 1993-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Free cash flow: -17370000 USD Concept: free-cash-flow Period: 1992-04-01 to 1993-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15589000 USD (1992-04-01 to 1993-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-95-004935.txt#7272 Input fundies:CapitalExpenditure: 1781000 USD (1992-04-01 to 1993-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-95-004935.txt#7276 The citation records this snapshot. The page link may show a newer release later.
1994 1993-04-01 – 1994-03-31	−USD 18.8 million Exact value Exact value: -18800000 USD 1993-04-01 – 1994-03-31: -18800000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR BIOSYSTEMS INC · 1994-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Net Income: -18800000 USD Concept: fundies:NetIncome Period: 1993-04-01 to 1994-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ANetIncome&period=1994-03-31&surface=latest&period_type=duration&start=1993-04-01&unit=USD&dimensions= Input fundies:NetIncome: -18800000 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-96-013538.txt#5868 The citation records this snapshot. The page link may show a newer release later.	−USD 14.66 million Exact value Exact value: -14664000 USD 1993-04-01 – 1994-03-31: -14664000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR BIOSYSTEMS INC · 1994-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Operating Cash Flow: -14664000 USD Concept: fundies:OperatingCashFlow Period: 1993-04-01 to 1994-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3AOperatingCashFlow&period=1994-03-31&surface=latest&period_type=duration&start=1993-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14664000 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-96-013538.txt#5885 The citation records this snapshot. The page link may show a newer release later.	USD 8.21 million Exact value Exact value: 8208000 USD 1993-04-01 – 1994-03-31: 8208000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR BIOSYSTEMS INC · 1994-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Capital Expenditure: 8208000 USD Concept: fundies:CapitalExpenditure Period: 1993-04-01 to 1994-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ACapitalExpenditure&period=1994-03-31&surface=latest&period_type=duration&start=1993-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8208000 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-96-013538.txt#5889 The citation records this snapshot. The page link may show a newer release later.	−USD 22.87 million Calculation and evidence -14664000 − 8208000 USD Exact free cash flow: -22872000 USD 1993-04-01 – 1994-03-31: -14664000 USD · Inspect Operating Cash Flow · Source 1993-04-01 – 1994-03-31: 8208000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR BIOSYSTEMS INC · 1994-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Free cash flow: -22872000 USD Concept: free-cash-flow Period: 1993-04-01 to 1994-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14664000 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-96-013538.txt#5885 Input fundies:CapitalExpenditure: 8208000 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-96-013538.txt#5889 The citation records this snapshot. The page link may show a newer release later.
1995 1994-04-01 – 1995-03-31	−USD 12.18 million Exact value Exact value: -12182000 USD 1994-04-01 – 1995-03-31: -12182000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR BIOSYSTEMS INC · 1995-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Net Income: -12182000 USD Concept: fundies:NetIncome Period: 1994-04-01 to 1995-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ANetIncome&period=1995-03-31&surface=latest&period_type=duration&start=1994-04-01&unit=USD&dimensions= Input fundies:NetIncome: -12182000 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-97-018610.txt#2276 The citation records this snapshot. The page link may show a newer release later.	−USD 11.51 million Exact value Exact value: -11506000 USD 1994-04-01 – 1995-03-31: -11506000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR BIOSYSTEMS INC · 1995-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Operating Cash Flow: -11506000 USD Concept: fundies:OperatingCashFlow Period: 1994-04-01 to 1995-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3AOperatingCashFlow&period=1995-03-31&surface=latest&period_type=duration&start=1994-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11506000 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-96-013538.txt#5885 The citation records this snapshot. The page link may show a newer release later.	USD 2.53 million Exact value Exact value: 2528000 USD 1994-04-01 – 1995-03-31: 2528000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR BIOSYSTEMS INC · 1995-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Capital Expenditure: 2528000 USD Concept: fundies:CapitalExpenditure Period: 1994-04-01 to 1995-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ACapitalExpenditure&period=1995-03-31&surface=latest&period_type=duration&start=1994-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2528000 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-96-013538.txt#5889 The citation records this snapshot. The page link may show a newer release later.	−USD 14.03 million Calculation and evidence -11506000 − 2528000 USD Exact free cash flow: -14034000 USD 1994-04-01 – 1995-03-31: -11506000 USD · Inspect Operating Cash Flow · Source 1994-04-01 – 1995-03-31: 2528000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR BIOSYSTEMS INC · 1995-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Free cash flow: -14034000 USD Concept: free-cash-flow Period: 1994-04-01 to 1995-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11506000 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-96-013538.txt#5885 Input fundies:CapitalExpenditure: 2528000 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-96-013538.txt#5889 The citation records this snapshot. The page link may show a newer release later.
1996 1995-04-01 – 1996-03-31	−USD 20.71 million Exact value Exact value: -20713000 USD 1995-04-01 – 1996-03-31: -20713000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR BIOSYSTEMS INC · 1996-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Net Income: -20713000 USD Concept: fundies:NetIncome Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ANetIncome&period=1996-03-31&surface=latest&period_type=duration&start=1995-04-01&unit=USD&dimensions= Input fundies:NetIncome: -20713000 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0001047469-98-025475.txt#2412 The citation records this snapshot. The page link may show a newer release later.	−USD 12.07 million Exact value Exact value: -12069000 USD 1995-04-01 – 1996-03-31: -12069000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR BIOSYSTEMS INC · 1996-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Operating Cash Flow: -12069000 USD Concept: fundies:OperatingCashFlow Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3AOperatingCashFlow&period=1996-03-31&surface=latest&period_type=duration&start=1995-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12069000 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0001047469-98-025475.txt#2428 The citation records this snapshot. The page link may show a newer release later.	USD 2.4 million Exact value Exact value: 2397000 USD 1995-04-01 – 1996-03-31: 2397000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR BIOSYSTEMS INC · 1996-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Capital Expenditure: 2397000 USD Concept: fundies:CapitalExpenditure Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ACapitalExpenditure&period=1996-03-31&surface=latest&period_type=duration&start=1995-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2397000 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0001047469-98-025475.txt#2433 The citation records this snapshot. The page link may show a newer release later.	−USD 14.47 million Calculation and evidence -12069000 − 2397000 USD Exact free cash flow: -14466000 USD 1995-04-01 – 1996-03-31: -12069000 USD · Inspect Operating Cash Flow · Source 1995-04-01 – 1996-03-31: 2397000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR BIOSYSTEMS INC · 1996-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Free cash flow: -14466000 USD Concept: free-cash-flow Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12069000 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0001047469-98-025475.txt#2428 Input fundies:CapitalExpenditure: 2397000 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0001047469-98-025475.txt#2433 The citation records this snapshot. The page link may show a newer release later.
1997 1996-04-01 – 1997-03-31	−USD 13.28 million Exact value Exact value: -13284000 USD 1996-04-01 – 1997-03-31: -13284000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR BIOSYSTEMS INC · 1997-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Net Income: -13284000 USD Concept: fundies:NetIncome Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ANetIncome&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:NetIncome: -13284000 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-025853.txt#1100 The citation records this snapshot. The page link may show a newer release later.	−USD 13.48 million Exact value Exact value: -13475000 USD 1996-04-01 – 1997-03-31: -13475000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR BIOSYSTEMS INC · 1997-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Operating Cash Flow: -13475000 USD Concept: fundies:OperatingCashFlow Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3AOperatingCashFlow&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13475000 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-025853.txt#1116 The citation records this snapshot. The page link may show a newer release later.	USD 726,000 Exact value Exact value: 726000 USD 1996-04-01 – 1997-03-31: 726000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR BIOSYSTEMS INC · 1997-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Capital Expenditure: 726000 USD Concept: fundies:CapitalExpenditure Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ACapitalExpenditure&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 726000 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-025853.txt#1120 The citation records this snapshot. The page link may show a newer release later.	−USD 14.2 million Calculation and evidence -13475000 − 726000 USD Exact free cash flow: -14201000 USD 1996-04-01 – 1997-03-31: -13475000 USD · Inspect Operating Cash Flow · Source 1996-04-01 – 1997-03-31: 726000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR BIOSYSTEMS INC · 1997-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Free cash flow: -14201000 USD Concept: free-cash-flow Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13475000 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-025853.txt#1116 Input fundies:CapitalExpenditure: 726000 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-025853.txt#1120 The citation records this snapshot. The page link may show a newer release later.
1998 1997-04-01 – 1998-03-31	−USD 21.26 million Exact value Exact value: -21260000 USD 1997-04-01 – 1998-03-31: -21260000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR BIOSYSTEMS INC · 1998-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Net Income: -21260000 USD Concept: fundies:NetIncome Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ANetIncome&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:NetIncome: -21260000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1740 The citation records this snapshot. The page link may show a newer release later.	−USD 17.46 million Exact value Exact value: -17459000 USD 1997-04-01 – 1998-03-31: -17459000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR BIOSYSTEMS INC · 1998-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Operating Cash Flow: -17459000 USD Concept: fundies:OperatingCashFlow Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3AOperatingCashFlow&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17459000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1755 The citation records this snapshot. The page link may show a newer release later.	USD 1.39 million Exact value Exact value: 1387000 USD 1997-04-01 – 1998-03-31: 1387000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR BIOSYSTEMS INC · 1998-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Capital Expenditure: 1387000 USD Concept: fundies:CapitalExpenditure Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ACapitalExpenditure&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1387000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1758 The citation records this snapshot. The page link may show a newer release later.	−USD 18.85 million Calculation and evidence -17459000 − 1387000 USD Exact free cash flow: -18846000 USD 1997-04-01 – 1998-03-31: -17459000 USD · Inspect Operating Cash Flow · Source 1997-04-01 – 1998-03-31: 1387000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR BIOSYSTEMS INC · 1998-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Free cash flow: -18846000 USD Concept: free-cash-flow Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17459000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1755 Input fundies:CapitalExpenditure: 1387000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1758 The citation records this snapshot. The page link may show a newer release later.
1999 1998-04-01 – 1999-03-31	−USD 21.24 million Exact value Exact value: -21240000 USD 1998-04-01 – 1999-03-31: -21240000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR BIOSYSTEMS INC · 1999-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Net Income: -21240000 USD Concept: fundies:NetIncome Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ANetIncome&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:NetIncome: -21240000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1740 The citation records this snapshot. The page link may show a newer release later.	−USD 26.53 million Exact value Exact value: -26528000 USD 1998-04-01 – 1999-03-31: -26528000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR BIOSYSTEMS INC · 1999-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Operating Cash Flow: -26528000 USD Concept: fundies:OperatingCashFlow Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3AOperatingCashFlow&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26528000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1755 The citation records this snapshot. The page link may show a newer release later.	USD 791,000 Exact value Exact value: 791000 USD 1998-04-01 – 1999-03-31: 791000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR BIOSYSTEMS INC · 1999-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Capital Expenditure: 791000 USD Concept: fundies:CapitalExpenditure Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ACapitalExpenditure&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 791000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1758 The citation records this snapshot. The page link may show a newer release later.	−USD 27.32 million Calculation and evidence -26528000 − 791000 USD Exact free cash flow: -27319000 USD 1998-04-01 – 1999-03-31: -26528000 USD · Inspect Operating Cash Flow · Source 1998-04-01 – 1999-03-31: 791000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR BIOSYSTEMS INC · 1999-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Free cash flow: -27319000 USD Concept: free-cash-flow Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -26528000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1755 Input fundies:CapitalExpenditure: 791000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1758 The citation records this snapshot. The page link may show a newer release later.
2000 1999-04-01 – 2000-03-31	−USD 7.57 million Exact value Exact value: -7568000 USD 1999-04-01 – 2000-03-31: -7568000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MOLECULAR BIOSYSTEMS INC · 2000-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Net Income: -7568000 USD Concept: fundies:NetIncome Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ANetIncome&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:NetIncome: -7568000 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1740 The citation records this snapshot. The page link may show a newer release later.	−USD 3.53 million Exact value Exact value: -3525000 USD 1999-04-01 – 2000-03-31: -3525000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MOLECULAR BIOSYSTEMS INC · 2000-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Operating Cash Flow: -3525000 USD Concept: fundies:OperatingCashFlow Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3AOperatingCashFlow&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3525000 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1755 The citation records this snapshot. The page link may show a newer release later.	USD 13,000 Exact value Exact value: 13000 USD 1999-04-01 – 2000-03-31: 13000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MOLECULAR BIOSYSTEMS INC · 2000-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Capital Expenditure: 13000 USD Concept: fundies:CapitalExpenditure Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598/explain?concept=fundies%3ACapitalExpenditure&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13000 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1758 The citation records this snapshot. The page link may show a newer release later.	−USD 3.54 million Calculation and evidence -3525000 − 13000 USD Exact free cash flow: -3538000 USD 1999-04-01 – 2000-03-31: -3525000 USD · Inspect Operating Cash Flow · Source 1999-04-01 – 2000-03-31: 13000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MOLECULAR BIOSYSTEMS INC · 2000-03-31 MOLECULAR BIOSYSTEMS INC (edgar:719598) Free cash flow: -3538000 USD Concept: free-cash-flow Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719598?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3525000 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1755 Input fundies:CapitalExpenditure: 13000 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719598/0000912057-00-029586.txt#1758 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

30 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000719598, 719598, edgar:719598

MOLECULAR BIOSYSTEMS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2000 1999-04-01 – 2000-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation